Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Tadalafil and Finasteride may help treat aggressive melanoma.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Peptide drugs now target hard-to-reach proteins more effectively and specifically.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

The p53 protein has complex, sometimes contradictory functions, including tumor suppression and promoting cell survival.

Mdm2 is crucial for controlling p53 to maintain healthy cells and prevent tumors.

Asiasari radix extract may be a potential treatment for melanoma because it selectively triggers cell death in melanoma cells by affecting p53 regulation.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Maintaining DNA health in stem cells is key to preventing aging and tissue breakdown.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Minoxidil prevents serotonin loss from MDMA by affecting potassium channels and increasing Akt phosphorylation.

MXD@CP could be a promising new topical treatment for hair loss.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

DFMO may help control hair growth and treat cancer.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

Some minoxidil combinations can help differentiate leukemia cells without harming other cells.

Minoxidil may help treat myelodysplastic syndrome without harming normal blood cell production.

The MXD/24HA salt is more effective for hair growth than raw MXD.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

The new minoxidil formulation could better promote hair growth for treating androgenic alopecia.

Combining dutasteride mesotherapy with oral minoxidil is more effective for hair loss than using oral minoxidil alone.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.